Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
Tonight I think I’ll share some of my favorite shorts – – I only got through the first three letters of the alphabet before I had enough symbols, such we’ll just do A through C. These are all “live” positions, and they’re all short (naturally).
First up is Acadia Pharmaceuticals, which has a well-defined diamond topping pattern (as always, click on the SlopeCharts image for a bigger version).
One of my favorite studies is one that isn’t seen much, and it’s called a ribbon study. It’s the application of a large quantity of moving averages (sixteen, I think) that are relatively close in periodicity, thus forming a ribbon-like structure around price that twists and turns. It tends to get denser (and darker) at inflection points (or at least points of inactivity).
I applied it to the VIX, as shown below, hiding the price data itself and showing only the study. I’m not going to pretend any great insight leapt out of this chart, but maybe it will for you. If nothing else, it’s real purty.
Further to my post of September 25 (regarding GOP legislation failures), watch for an increase in volatility and a potential rotation out of equities (SPX) and into commodities (GOLD and OIL) and currencies (US Dollar) for Q4 of 2017.
With respect to volatility, watch for a potential “SELL” signal to form on the RSI, MACD and PMO technical indicators, as price whipsaws in between major resistance at 250 and major support at 200, as shown on the following SPX:VIX ratio chart.